Page last updated: 2024-11-05

tiopronin and Lung Diseases, Interstitial

tiopronin has been researched along with Lung Diseases, Interstitial in 2 studies

Tiopronin: Sulfhydryl acylated derivative of GLYCINE.

Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sayag-Boukris, V1
Cadranel, J1
Ziza, JM1
Mayaud, C1
Berthelot, JM1
Lalande, S1
Charlieer, C1
Maugars, Y1
Prost, A1

Other Studies

2 other studies available for tiopronin and Lung Diseases, Interstitial

ArticleYear
Tiopronin-induced acute interstitial pneumonitis.
    Revue du rhumatisme (English ed.), 1995, Volume: 62, Issue:5

    Topics: Acute Disease; Aged; Humans; Lung Diseases, Interstitial; Male; Tiopronin

1995
["Hyper-acute" interstitial pneumopathy in a patient treated with tiopronin].
    Revue du rhumatisme (Ed. francaise : 1993), 1994, Volume: 61, Issue:3

    Topics: Acute Disease; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Tiopronin

1994